Prescription drug · ANDA
Aripiprazole NDC 70518-4745
Aripiprazole 15 mg/1 · Tablet · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4745-0 | 70518474500 | 50 POUCH in 1 BOX (70518-4745-0) / 1 TABLET in 1 POUCH (70518-4745-1)Marketed from Sep 8, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aripiprazole
- Generic name (nonproprietary)
- aripiprazole
- Active ingredients
- Aripiprazole — 15 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- REMEDYREPACK INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203908
- Marketing start
- Listing expires
- Identifiers
- Product ID 70518-4745_5afeb539-34e3-066d-e063-6394a90a3112SPL ID 5afeb539-34e3-066d-e063-6394a90a3112SPL set ID b72c0cff-9f4d-42e2-b884-d06dea3e6378RxCUI 349490UNII 82VFR53I78
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518474500followed by a unit qualifier and the quantityPackage 70518-4745-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Aripiprazole tablets are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. Aripiprazole tablets are indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder ( 14.2 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s Disorder ( 14.5 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203908
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | A-S Medication Solutions | 50090-6403 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-662 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-661 |
| Aripiprazole | Aripiprazole 30 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-666 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-663 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-664 |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-665 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Proficient Rx LP | 71205-392 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Proficient Rx LP | 71205-480 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Proficient Rx LP | 82804-023 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | A-S Medication Solutions | 50090-7564 |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1364 |